What this means
BALSALAZIDE DISODIUM is the active ingredient in COLAZAL / GIAZO (marketed by VALEANT PHARMACEUTICALS INTERNATIONAL). Available as capsule;oral, tablet;oral. First approved 2000 — 25 years on market. Currently protected by 6 patents. The earliest market opportunity is 2026-08-01 — only 50 days away. Urgent. 6 ANDAs already filed — competitive space. Bottom line: near-term opportunity worth evaluating against your portfolio.
| Patent | Type | Expiry | Verdict |
|---|---|---|---|
| US 9192616 ↗US 9192616 | U-1229 | 2026-08-01 | — |
| Test patent linked to FDA Orange Book — US 7625884US 7625884 | U-1229 | 2026-08-23 | Medium 65 |
| US 7452872 ↗US 7452872 | U-1229 | 2026-08-23 | — |
| US 7452872*PED ↗US 7452872*PED | 2027-02-23 | — | |
| US 7625884*PED ↗US 7625884*PED | 2027-02-23 | — | |
| US 8497256 ↗US 8497256 | U-1229 | 2031-06-22 | — |
750MG · CAPSULE;ORAL · approved 2000-07-17 · VALEANT PHARMACEUTICALS INTERNATIONAL
1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET;ORAL · approved 2012-02-02 · VALEANT PHARMACEUTICALS INTERNATIONAL
750MG · approved 2007-12-27
750MG · approved 2025-04-02
750MG · approved 2007-12-27
750MG · approved 2007-12-27
750MG · approved 2023-06-07
1.1GM · approved 2015-09-07